Liu, Longbin – Trademark Portfolio

Entity Type: 01

Liu, Longbin holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AAZ, XOZ, and ONESEE. The owner is based in Sichuan.

Group 3, Huangling Village

Dongsheng Town, Yingshan County

Sichuan 637700 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ONESEE
ONESEE
Registered 2021
XOZ
XOZ
Registered 2021
AAZ
AAZ
Registered 2020

Trademark Classifications

Liu, Longbin's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Liu, Longbin have?

Liu, Longbin has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Liu, Longbin file in?

Liu, Longbin files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Liu, Longbin's most well-known trademarks?

Liu, Longbin's registered trademark portfolio includes well-known marks such as AAZ, XOZ, and ONESEE. These are among 3 currently registered trademarks in the portfolio.

What is Liu, Longbin's trademark registration success rate?

Liu, Longbin has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.